‌

US Patent 11866418 Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

Patent 11866418 was granted and assigned to BioCryst Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

BioCryst Pharmaceuticals

0

Current Assignee

BioCryst Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Minwan Wu0

Wei Lv0

Weihe Zhang0

V. Satish Kumar0

Venkat R. Chintareddy0

Pravin L. Kotian0

Trung Xuan Nguyen0

Krishnan Raman0

...

Date of Patent

January 9, 2024

0

Patent Application Number

177304380

Date Filed

April 27, 2022

0

Patent Citations

US Patent 7442808 Antidiabetic bicyclic compounds

0

US Patent 9056874 Complement pathway modulators and uses thereof

0

US Patent 11708347 Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

0

US Patent 11021458 Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

0

US Patent 11370774 Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

0

Patent Citations Received

0

Patent Primary Examiner

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11866418 Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool